Vanguard Group Inc Chimerix Inc Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Chimerix Inc stock. As of the latest transaction made, Vanguard Group Inc holds 4,330,398 shares of CMRX stock, worth $14.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,330,398
Previous 4,345,579
0.35%
Holding current value
$14.5 Million
Previous $3.82 Million
5.31%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CMRX
# of Institutions
70Shares Held
37MCall Options Held
52.7KPut Options Held
130K-
Ra Capital Management, L.P. Boston, MA8.8MShares$29.4 Million0.11% of portfolio
-
Monaco Asset Management Sam4.22MShares$14.1 Million0.58% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.4MShares$8 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY2.21MShares$7.37 Million0.03% of portfolio
-
Acadian Asset Management LLC Boston, MA2.19MShares$7.31 Million0.01% of portfolio
About CHIMERIX INC
- Ticker CMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,622,896
- Market Cap $293M
- Description
- Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...